Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings

Andrea Jane Curtis; Catherine Marshall; Tim Denis Spelman; Jane Greig; Julian Elliott; Leslie Shanks; Philipp Du Cros; Esther C Casas; Marcio Silveria Da Fonseca; Daniel O'Brien

doi:10.1371/journal.pone.0052019

Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings

Andrea Jane Curtis, Catherine Marshall, Tim Denis Spelman, Jane Greig, Julian Elliott, Leslie Shanks, Philipp Du Cros, Esther C Casas, Marcio Silveria Da Fonseca, Daniel O'Brien

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

12 Citations (Scopus)

Abstract

The incidence of WHO stage 3 and 4 conditions during the early period after ART initiation in RLS is high, but greatly reduces over time. This is likely due to both the benefits of ART and deaths of the sickest patients occurring shortly after ART initiation. Access to appropriate disease prevention tools prior to ART, and early initiation of ART, are important for their prevention.

Original language	English
Article number	e52019
Number of pages	9
Journal	PLoS ONE
Volume	7
Issue number	12
DOIs	https://doi.org/10.1371/journal.pone.0052019
Publication status	Published - 2012

Access to Document

10.1371/journal.pone.0052019Licence: CC BY

Cite this

@article{bf99b9c8c93348ae88de73d84c1e6471,

title = "Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings",

abstract = "The incidence of WHO stage 3 and 4 conditions during the early period after ART initiation in RLS is high, but greatly reduces over time. This is likely due to both the benefits of ART and deaths of the sickest patients occurring shortly after ART initiation. Access to appropriate disease prevention tools prior to ART, and early initiation of ART, are important for their prevention.",

author = "Curtis, {Andrea Jane} and Catherine Marshall and Spelman, {Tim Denis} and Jane Greig and Julian Elliott and Leslie Shanks and {Du Cros}, Philipp and Casas, {Esther C} and {Da Fonseca}, {Marcio Silveria} and Daniel O'Brien",

year = "2012",

doi = "10.1371/journal.pone.0052019",

language = "English",

volume = "7",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science (PLoS)",

number = "12",

}

TY - JOUR

T1 - Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings

AU - Curtis, Andrea Jane

AU - Marshall, Catherine

AU - Spelman, Tim Denis

AU - Greig, Jane

AU - Elliott, Julian

AU - Shanks, Leslie

AU - Du Cros, Philipp

AU - Casas, Esther C

AU - Da Fonseca, Marcio Silveria

AU - O'Brien, Daniel

PY - 2012

Y1 - 2012

N2 - The incidence of WHO stage 3 and 4 conditions during the early period after ART initiation in RLS is high, but greatly reduces over time. This is likely due to both the benefits of ART and deaths of the sickest patients occurring shortly after ART initiation. Access to appropriate disease prevention tools prior to ART, and early initiation of ART, are important for their prevention.

AB - The incidence of WHO stage 3 and 4 conditions during the early period after ART initiation in RLS is high, but greatly reduces over time. This is likely due to both the benefits of ART and deaths of the sickest patients occurring shortly after ART initiation. Access to appropriate disease prevention tools prior to ART, and early initiation of ART, are important for their prevention.

UR - http://www.plosone.org/article/info:doi/10.1371/journal.pone.0052019

U2 - 10.1371/journal.pone.0052019

DO - 10.1371/journal.pone.0052019

M3 - Article

SN - 1932-6203

VL - 7

JO - PLoS ONE

JF - PLoS ONE

IS - 12

M1 - e52019

ER -

Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings

Abstract

Access to Document

Other files and links

Understanding and preventing chronic disease in people living with HIV

Cite this

Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings

Abstract

Access to Document

Other files and links

Projects

Understanding and preventing chronic disease in people living with HIV

Cite this